Collegium Pharmaceutical COLL August 2022 Investor Presentation

Collegium Pharmaceutical corporate and investor presentation from August 2022 covering full-year 2022 financial guidance, adjusted EBITDA, and operating expenses. The deck includes forward-looking statements and non-GAAP financial measures, and discusses recent BDSI acquisition integration and commercialization strategy.